ICU Medical (ICUI) Tops Q4 EPS by 4c; Offers FY23 EPS Guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.60, $0.04 better than the analyst estimate of $1.56. Revenue for the quarter came in at $578 million versus the consensus estimate of $578.77 million.

GUIDANCE:

ICU Medical sees FY2023 EPS of $5.75-$7.25, versus the consensus of $7.22.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• S&P Global completes acquisition of datacenterHawk